CBS 2019
CBSMD教育中心
中 文

Percutaneous LAA Occlusion

Abstract

Recommended Article

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation: JACC Review Topic of the Week Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

JOURNAL: Article Link

CBS2025丨聚焦前沿,专家云集!学术盛会注册现已开放,诚邀您的参与

qiaomingyue Keywords: 江畔论道,智汇秦淮。“第十七届左主干暨冠状动脉分叉病变会议(CBS2025)”将于2025年11月28日至30日在南京国际青年会议酒店隆重召开。同期,会议还将举办“全国心血管疾病管理能力评估与提升工程(CDQI)国家标准化肺血管病中心年会”。本次会议由北京合众关爱心脏健康基金会主办,南京市第一医院、南京市心血管病医院、南京医科大学附属南京医院、亚洲分叉病变俱乐部(ABC)、CDQI国家标准化肺血管病中心共同承办。

网站资料更新中...